Literature DB >> 9288975

Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.

Q R Fan1, L Mosyak, C C Winter, N Wagtmann, E O Long, D C Wiley.   

Abstract

Abnormal cells deficient in class I major histocompatibility complex (MHC) expression are lysed by a class of lymphocytes called natural killer (NK) cells. This lysis provides a defence against pathogens and tumour cells that downregulate MHC expression to avoid an MHC-restricted, T-cell immune response. Normal cells escape lysis because their MHC molecules are recognized by NK-cell inhibitory receptors, which inhibit lysis. Several such inhibitory receptor families have been described in humans and mice. In the human killer-cell inhibitory receptor family, individual p58 members are specific for a subset of class I human leukocyte antigen (HLA)-C molecules. The human p58 natural killer-cell inhibitory receptor clone 42 recognizes HLA-Cw4, -Cw2 and -Cw6, but not HLA-Cw3, -Cw2, -Cw7 or -Cw8, which are recognized by p58 killer-cell inhibitor receptor clone 43. We have determined the X-ray structure of the p58 NK-cell inhibitory receptor clone 42 at 1.7-A resolution. The structure has tandem immunoglobulin-like domains positioned at an acute, 60-degree angle. Loops on the outside of the elbow between the domains form a binding site projected away from the NK-cell surface. The topology of the domains and their arrangement relative to each other reveal a relationship to the haematopoietic receptor family, with implications for the signalling mechanism in NK cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288975     DOI: 10.1038/38028

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  43 in total

1.  The human natural killer cell immune synapse.

Authors:  D M Davis; I Chiu; M Fassett; G B Cohen; O Mandelboim; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.

Authors:  C C Chen; V Hurez; J S Brockenbrough; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

4.  Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.

Authors:  Hugo G Hilton; Lisbeth A Guethlein; Ana Goyos; Neda Nemat-Gorgani; David A Bushnell; Paul J Norman; Peter Parham
Journal:  J Immunol       Date:  2015-08-26       Impact factor: 5.422

Review 5.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

6.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

7.  The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus.

Authors:  Jennifer L Baltz; David J Filman; Mihai Ciustea; Janice Elaine Y Silverman; Catherine L Lautenschlager; Donald M Coen; Robert P Ricciardi; James M Hogle
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

8.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

9.  Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11.

Authors:  Jingxian Liu; Ziwei Xiao; Hui Ling Ko; Meixin Shen; Ee Chee Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

10.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.